Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H4444

Provider Partners Health Plans

4,426 members

3.5

Below the 4 star line

Ask about H4444

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

2 · 1.0 pt to 3★

Medication Adherence for Hypertension (RAS antagonists)

3 · 2.0 pt to 4★

Medication Adherence for Cholesterol (Statins)

4 · 3.0 pt to 5★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan50.13
C28 Members Choosing to Leave the Plan57%
C13 Kidney Health Evaluation for Patients with Diabetes246%
C30 Plan Makes Timely Decisions about Appeals173%
C11 Diabetes Care – Eye Exam375%
C31 Reviewing Appeals Decisions176%
C12 Diabetes Care – Blood Sugar Controlled3x387%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions592%
C32 Call Center – Foreign Language Interpreter and TTY Availability394%
C07 Special Needs Plan (SNP) Care Management599%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.